The system processes a standard blood draw to concentrate the body’s natural cell-derived particles. By utilizing a patient's own biology, practitioners can integrate these concentrated components into individualized aesthetic protocols. According to CEO Erik Dowell, the move represents a logical progression for the brand, leveraging an established global platform to offer deeper customization in clinical settings.
Aesthetic Management Partners Debuts Cellenis® Exo-ME™ Skin Booster
Aesthetic Management Partners has launched Cellenis® Exo-ME™, a point-of-care system that isolates autologous extracellular vesicles and bioactive proteins from a patient's own blood. The new technology expands the existing Cellenis® PRP portfolio, aiming to provide a personalized biological approach to aesthetic skin and scalp rejuvenation treatments.
Extracellular vesicles are currently a focal point of ongoing scientific research, and this device brings that focus directly into the skin-booster market. The technology serves as a new tool for providers looking to move beyond traditional fillers, offering a tailored preparation for both hair and scalp care applications. Aesthetic Management Partners continues to position these blood-derived treatments as a central component of their clinical support offerings.
Comments (0)
No comments yet. Be the first!